Cited by

• Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment.

  Kim HJ, Park SK, Yang HJ, Jung YS, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Choi KY. Kim HJ, et al. Clin Mol Hepatol. 2016 Sep;22(3):350-358. doi: 10.3350/cmh.2016.0019. Epub 2016 Sep 25. Clin Mol Hepatol. 2016. PMID: 27729626 Free PMC article.
• Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine.

  Hosaka T, Suzuki F, Suzuki Y, Saitoh S, Kobayashi M, Someya T, Sezaki H, Akuta N, Arase Y, Ikeda K, Kumada H. Hosaka T, et al. J Gastroenterol. 2007 May;42(5):368-74. doi: 10.1007/s00535-007-2008-1. Epub 2007 May 25. J Gastroenterol. 2007. PMID: 17530361
• Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study.

  Yu S, Zhou Q, Zhao XM, Yuan M, Wang CT, Cheng XG, Zhang ZH, Li X. Yu S, et al. Saudi J Gastroenterol. 2014 Nov-Dec;20(6):350-5. doi: 10.4103/1319-3767.145320. Saudi J Gastroenterol. 2014. PMID: 25434315 Free PMC article. Clinical Trial.
• Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.

  Rambaldi A, Jacobs BP, Gluud C. Rambaldi A, et al. Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003620. doi: 10.1002/14651858.CD003620.pub3. Cochrane Database Syst Rev. 2007. PMID: 17943794 Free PMC article.
• The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis.

  Xie QL, Zhu Y, Wu LH, Fu LL, Xiang Y. Xie QL, et al. PLoS One. 2015 Jul 30;10(7):e0132219. doi: 10.1371/journal.pone.0132219. eCollection 2015. PLoS One. 2015. PMID: 26226455 Free PMC article.